Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2433 (LINC02433)

Target
LINC02433
Molecular classification
Other (Long non-coding RNA), Non-protein coding gene, Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2433 (LINC02433) is a human lincRNA gene, annotated in genome databases as a non-protein coding transcript. LincRNAs are typically more than 200 nucleotides in length, lack significant open reading frames, and do not overlap classical protein-coding regions. The broader class of lincRNAs is now recognized to shape chromatin, regulate transcriptional and post-transcriptional gene expression, and demonstrate cell– and tissue–specificity. Although some lincRNAs play important roles in disease, development, and gene regulation, there is currently no published evidence describing a specific function, disease association, or drug interaction for LINC02433 itself. LINC02433 remains an uncharacterized member of the human lincRNA family.

Other names
LINC02433Long intergenic non-protein coding RNA 2433
02

Mechanism of action

Not applicable. lincRNAs are not typical drug targets and drug mechanisms for this gene are currently unknown. Mechanistically, lincRNAs may modulate gene expression, chromatin structure, or act as scaffolds for protein complexes.

03

Biological functions

Putative epigenetic or gene expression regulationPossible fine-tuning of neighboring gene expressionlincRNAs are involved in chromatin remodeling and RNA stabilizationPotential transcription regulation, frequently with tissue-specific activitiesNo published functional studies were found for LINC02433 specifically.
04

Disease associations

No direct evidence for involvement in specific diseases for LINC02433 was found.In general, lincRNAs can be implicated in cancer, neurodegenerative disease, cell cycle disorders, and may act as biomarkers or regulatory elements in human disease.These are general to the molecular family, not LINC02433 specifically.
05

Safety considerations

Not applicable. There are no safety concerns or therapeutic challenges associated specifically with targeting LINC02433.In general, targeting non-coding RNAs may present unexpected pleiotropic effects or off-target gene regulation, but no specific data for LINC02433 exist.
06

Interacting drugs

None. There are currently no known drugs reported to directly interact with LINC02433.

1 more in the full profile.

07

Biomarkers

None reported for LINC02433.Other lincRNAs serve as clinical biomarkers; this is not shown for LINC02433 in any source.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2433 (LINC02433).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2433 (LINC02433).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call